129 related articles for article (PubMed ID: 25531985)
1. Sex-specific urinary biomarkers for diagnosing bipolar disorder.
Chen JJ; Huang H; Zhao LB; Zhou DZ; Yang YT; Zheng P; Yang DY; He P; Zhou JJ; Fang L; Xie P
PLoS One; 2014; 9(12):e115221. PubMed ID: 25531985
[TBL] [Abstract][Full Text] [Related]
2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
3. Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.
Chen JJ; Liu Z; Fan SH; Yang DY; Zheng P; Shao WH; Qi ZG; Xu XJ; Li Q; Mu J; Yang YT; Xie P
Sci Rep; 2014 Jul; 4():5855. PubMed ID: 25068480
[TBL] [Abstract][Full Text] [Related]
4. 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.
Xu XJ; Zheng P; Ren GP; Liu ML; Mu J; Guo J; Cao D; Liu Z; Meng HQ; Xie P
Mol Biosyst; 2014 Apr; 10(4):813-9. PubMed ID: 24457555
[TBL] [Abstract][Full Text] [Related]
5. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of urinary metabolite biomarkers for major depressive disorder.
Zheng P; Wang Y; Chen L; Yang D; Meng H; Zhou D; Zhong J; Lei Y; Melgiri ND; Xie P
Mol Cell Proteomics; 2013 Jan; 12(1):207-14. PubMed ID: 23111923
[TBL] [Abstract][Full Text] [Related]
7. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
[TBL] [Abstract][Full Text] [Related]
8. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052
[TBL] [Abstract][Full Text] [Related]
9. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders.
Chen JJ; Bai SJ; Li WW; Zhou CJ; Zheng P; Fang L; Wang HY; Liu YY; Xie P
Transl Psychiatry; 2018 Sep; 8(1):192. PubMed ID: 30232320
[TBL] [Abstract][Full Text] [Related]
10. Towards a blood-based diagnostic panel for bipolar disorder.
Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolite signature in bipolar disorder patients during depressive episode.
Chen JJ; Xie J; Zeng L; Zhou CJ; Zheng P; Xie P
Aging (Albany NY); 2019 Feb; 11(3):1008-1018. PubMed ID: 30721880
[TBL] [Abstract][Full Text] [Related]
12. Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.
Zheng P; Chen JJ; Zhou CJ; Zeng L; Li KW; Sun L; Liu ML; Zhu D; Liang ZH; Xie P
Transl Psychiatry; 2016 Nov; 6(11):e955. PubMed ID: 27845778
[TBL] [Abstract][Full Text] [Related]
13. A multisystem composite biomarker as a preliminary diagnostic test in bipolar disorder.
Munkholm K; Vinberg M; Pedersen BK; Poulsen HE; Ekstrøm CT; Kessing LV
Acta Psychiatr Scand; 2019 Mar; 139(3):227-236. PubMed ID: 30383306
[TBL] [Abstract][Full Text] [Related]
14. PIAS genes as disease markers in bipolar disorder.
Sayad A; Taheri M; Azari I; Oskoei VK; Ghafouri-Fard S
J Cell Biochem; 2019 Aug; 120(8):12937-12942. PubMed ID: 30861611
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic analysis to detect urinary molecular changes associated with bipolar depression.
Ren Y; Chen ZZ; Sun XL; Duan HJ; Tian JS; Wang JY; Yang H
Neurosci Lett; 2021 Jan; 742():135515. PubMed ID: 33227370
[TBL] [Abstract][Full Text] [Related]
16. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
[TBL] [Abstract][Full Text] [Related]
17. A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.
Zhang W; Zhang XA
Cell Biochem Biophys; 2015 Jul; 72(3):661-7. PubMed ID: 27352185
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Profiling in Bipolar Disorder Patients During Depressive Episodes.
Ren Y; Bao S; Jia Y; Sun XL; Cao XX; Bai XY; Tian JS; Yang H
Front Psychiatry; 2020; 11():569612. PubMed ID: 33391044
[TBL] [Abstract][Full Text] [Related]
19. Disorder-specific volumetric brain difference in adolescent major depressive disorder and bipolar depression.
MacMaster FP; Carrey N; Langevin LM; Jaworska N; Crawford S
Brain Imaging Behav; 2014 Mar; 8(1):119-27. PubMed ID: 24158718
[TBL] [Abstract][Full Text] [Related]
20. Regional homogeneity of resting-state brain abnormalities in bipolar and unipolar depression.
Liu CH; Ma X; Wu X; Zhang Y; Zhou FC; Li F; Tie CL; Dong J; Wang YJ; Yang Z; Wang CY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Mar; 41():52-9. PubMed ID: 23200830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
